Dexamethasone reduces locomotor stimulation induced by dopamine agonists in mice.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 4
Abstract
The interaction between glucocorticosteroids and the dopaminergic system has attracted considerable attention in recent years since this link could be involved in certain psychopathological conditions including depression. Radioligand binding studies have shown the presence of glucocorticoid receptors in neurons of the limbic system, a structure involved in mood control and subtle regulation of hypothalamic-pituitary-adrenal (HPA) axis. Structures of the limbic system are also rich in dopaminergic innervation. It has been hypothesized that glucocorticoids may be important in causing and perpetuating depression. The aim of the present study was to investigate the effect of dexamethasone (DEX) on hyperactivity induced by dopamine agonists (amphetamine, amantadine, quinpirole and bromocriptine) in mice. Male Albino Swiss mice received DEX at a single dose (2, 4 or 8 mg/kg) or for 14 days at the doses of 0.5, 2 or 4 mg/kg/day. After a single or the last injection (in the chronic experiment) of DEX, dopamine agonists were given in the following regimen: D-amphetamine (0.4 mg/kg) and quinpirole (3 mg/kg) - 30 min, amantadine (50 mg/kg) - 60 min and bromocriptine (10 mg/kg) 180 min before the measurement of locomotor activity. The obtained results show that DEX may decrease the locomotor activity and reduce the hyperactivity induced by dopamine agonists in mice. These observations may suggest that DEX weakens the activity of dopamine agonists in the mesolimbic system.
Authors and Affiliations
Andrzej Wróbel, Iwona Żebrowska-Łupina, Marian Wielosz
Keywords
Related Articles
- EP ID EP91076
- DOI -
- Views 167
- Downloads 0
Central interaction between physostigmine and histamine during yawning in rats.
In this study, the effects of intraperitoneal (ip) injection of physostigmine, subcutaneous (sc) injection of atropine, and intracerebroventricular (icv) injections of histamine, chlorpheniramine (H(1)-receptor antagonis...
Possible contribution of IGF-1 to depressive disorder.
Depression is an illness of unknown origin and involves the dysregulation of many physiological processes disturbed in this disease. It has been postulated that the pathomechanism of depression is complex, and apart from...
Glial degeneration as a model of depression.
Major depression (MD) is a common and disabling disorder but knowledge of its pathophysiology is still incomplete. In the last years, degenerations or dysfunctions of glial cells, especially astrocytes, have been postula...
Effects of some new antiepileptic drugs and progabide on glucocorticoid receptor-mediated gene transcription in LMCAT cells.
Antiepileptic drugs affect endocrine and immune system activity, however, it is not clear whether these effects are indirect, via interference with neurotransmitters, membrane receptors and ion channels or maybe independ...
Medium supplementation with zinc enables detection of imipramine-induced adaptation in glycine/NMDA receptors labeled with [3H]L-689,560.
Antidepressant drugs after chronic administration induce adaptive changes in the NMDA receptor complex. Radioligand-receptorbinding studies using [3H]5,7-dichlorokynurenic acid demonstrated a "down-regulation" of the gly...